Gastric cancer: Classification, histology and application of molecular pathology. - Wikidata - awgldk - TriplyDB

Gastric cancer: Classification, histology and application of molecular pathology.

Gastric cancer: Classification, histology and application of molecular pathology.

http://www.wikidata.org/entity/Q34642023

about

Genomic alterations and molecular subtypes of gastric cancers in Asians HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the Stomach Molecular classification and prediction in gastric cancer Pathohistological classification systems in gastric cancer: diagnostic relevance and prognostic value Endoscopic Submucosal Dissection for Early Gastric Cancers with Uncommon Histology Hepatoid adenocarcinoma of the stomach--proper identification and treatment remain a challenge Roles of Erythroid Differentiation Regulator 1 (Erdr1) on Inflammatory Skin Diseases Role of periostin and its antagonist PNDA-3 in gastric cancer metastasis Imaging Patterns of Intratumoral Calcification in the Abdominopelvic Cavity.Physical activity domains and risk of gastric adenocarcinoma in the MCC-Spain case-control study.Presymptomatic identification of CDH1 germline mutation in a healthy korean individual with family history of gastric cancer.Towards personalized perioperative treatment for advanced gastric cancer.Prevention strategies for gastric cancer: a global perspective Biomarkers for gastric cancer: Progression in early diagnosis and prognosis (Review).Is endoscopic submucosal dissection safe for papillary adenocarcinoma of the stomach?Prospective comprehensive genomic profiling of advanced gastric carcinoma cases reveals frequent clinically relevant genomic alterations and new routes for targeted therapies.Correlation of Primary Tumor FDG Uptake with Histopathologic Features of Advanced Gastric Cancer.Ndrg2 promoter hypermethylation triggered by helicobacter pylori infection correlates with poor patients survival in human gastric carcinoma Ramucirumab (Cyramza): A Breakthrough Treatment for Gastric Cancer.Pathologic aspects of tumors of gastrointestinal tract in the era of personalized medicine Identifying therapeutic targets in gastric cancer: the current status and future direction Neuropilin-1 is associated with clinicopathology of gastric cancer and contributes to cell proliferation and migration as multifunctional co-receptors.MicroRNAs in hereditary diffuse gastric cancer.NKX6.3 Is a Transcription Factor for Wnt/β-catenin and Rho-GTPase Signaling-Related Genes to Suppress Gastric Cancer Progression Evaluation of c-Met, HGF, and HER-2 expressions in gastric carcinoma and their association with other clinicopathological factors.Prognostic Importance of Cell Cycle Regulators Cyclin D1 (CCND1) and Cyclin-Dependent Kinase Inhibitor 1B (CDKN1B/p27) in Sporadic Gastric Cancers.Comparison of lymph node number and prognosis in gastric cancer patients with perigastric lymph nodes retrieved by surgeons and pathologists.Metastatic spread in patients with gastric cancer.Gastric cancer and related epigenetic alterations.p53, a potential predictor of Helicobacter pylori infection-associated gastric carcinogenesis?Historical Perspective on Familial Gastric Cancer.Role of human epidermal growth factor receptor 2 in gastric cancer: biological and pharmacological aspects.Examining the gastric cancer survival gap between Asians and whites in the United States.Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea.Immunotherapeutic Strategies for Gastric Carcinoma: A Review of Preclinical and Clinical Recent Development.Moving molecular subtypes to the clinic in gastric cancer.Contribution of galectin-1, a glycan-binding protein, to gastrointestinal tumor progression.Expression of Cytokines Interleukin-2, Interleukin-4, Interleukin-10 and Transforming Growth Factor β in Gastric Adenocarcinoma Biopsies Obtained from Mexican Patients hsa-miR-29c and hsa-miR-135b differential expression as potential biomarker of gastric carcinogenesis.Evaluation of Slug expression is useful for predicting lymph node metastasis and survival in patients with gastric cancer.

P2860

Q26751062-071E39D4-CA17-45AF-BAD1-0A26789C4E34 Q26780318-AEBB1693-68FC-4C06-BC9F-3A3670F8E8D9 Q26783806-8949B6CF-F376-4513-AED7-E6CE27C9E63E Q26827351-F42919F4-CD12-4534-8029-1F8175B1A28F Q28069628-8AEF02C3-909E-40B7-AED1-E64AC6C9846A Q28073910-942417ED-F462-4A4A-81EC-BCE288A5788F Q28074548-78BC07B0-1357-4C0E-AC20-4B42E128D41E Q28088349-2AF45FF7-79DF-4B8D-B065-5826AB853942 Q30362334-15E6A404-2A76-4239-9475-090402086107 Q33880373-93DE4CF8-0D00-4E87-8A77-F725BDE304C5 Q34116651-E9F31E74-1C0D-4FF1-9D9D-AAE500262DC6 Q34137285-4BB7DAB9-018E-49D4-B355-DA3DF94512B3 Q34658645-28C2EFBC-A04A-4343-8837-23AAA48FF9A5 Q34668730-941252F5-DB91-49FE-9F34-51DB5DE13A5A Q35270334-48D3EA10-34D4-47F7-AC19-815FBC0EA357 Q35586700-E58DF48A-B345-4F65-AAA8-F451DFD5E336 Q35724980-22ECCEF6-CF05-4359-8590-02CC5636DCE1 Q35781542-F498D570-B6FE-4C8A-ABDF-857DF6F80F52 Q35831418-8AE95037-9750-4E96-909B-FB214771B633 Q36162507-A92ACDBE-E33C-4AD9-A5B4-59783BAAE935 Q36398732-B160FF5C-0358-431E-8247-247E960D1580 Q36489958-2057070F-773D-42A8-8C2D-F8BF7A0476E8 Q37106843-4A951537-17B3-4543-B2B6-F6DC672181A8 Q37149896-BAA5B65B-CABC-4D0E-A968-C0F8131AE752 Q37283371-5A70E9E7-6898-4894-9606-40DCF3F866CE Q37342600-CB8E7670-6B95-4E30-9FF6-F66B6704270C Q37402103-1B726E9F-74D7-41EF-BB3E-554157EC0AB8 Q37588449-B88F4000-240F-48FB-BD5B-F6F63CF47409 Q37592416-F6D9D913-3538-4E1D-AE5E-17097B3BBA2A Q37662406-F9B9ADA5-3705-4534-BA8B-B5E68ABE7481 Q37673618-1127E977-0260-4D22-8CE6-E4662F9BC20C Q37724647-A54D1E2A-A2E5-4732-AA33-096C771763C4 Q39171319-474D0A42-CC27-4FDE-A63D-D598ECA43F1B Q39400428-BA48AD18-DF24-448D-9B11-CD7A1228C4AF Q41110505-3979E181-4AE2-46CA-880C-22AE6FDB1572 Q41213684-F56DD70C-F480-497F-8242-E4547968F7C5 Q41334598-C28E92C5-7E97-4DB4-90D5-528865358750 Q41813201-64C89B74-AC51-4063-B0F5-3EC8F525C139 Q42020455-8DD2C654-4507-4D24-A983-86F32D5A82ED Q42084237-3080497C-61F1-4488-9A53-C3D5D65A5E20

P2860

Gastric cancer: Classification, histology and application of molecular pathology.

http://www.wikidata.org/entity/Q34642023

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Gastric cancer: Classification, histology and application of molecular pathology.

@ast

Gastric cancer: Classification, histology and application of molecular pathology.

@en

Gastric cancer: Classification, histology and application of molecular pathology.

@nl

type

label

Gastric cancer: Classification, histology and application of molecular pathology.

@ast

Gastric cancer: Classification, histology and application of molecular pathology.

@en

Gastric cancer: Classification, histology and application of molecular pathology.

@nl

prefLabel

Gastric cancer: Classification, histology and application of molecular pathology.

@ast

Gastric cancer: Classification, histology and application of molecular pathology.

@en

Gastric cancer: Classification, histology and application of molecular pathology.

@nl

P1433

Q34642023-E4BDE726-2918-42C0-AAC6-C32F2D923E11

P1476

Q34642023-D73FDDFD-4DAC-4BAE-BC2B-7B551F9483CE

P2093

Q34642023-5C57D6C3-8274-4225-9831-FD10CD8A4476

Q34642023-6CE9D030-1C7B-46CF-8B15-9913441E4358

Q34642023-76040F8D-5851-4972-95CB-E0C0F5883DC9

Q34642023-90A001FC-CC07-41D3-99A0-4BBEDFFD8509

Q34642023-BCEFB305-94E7-4D33-9A8F-F7127FAA95DD

Q34642023-F6808DF3-200A-4931-9249-2226873BBB34

P2860

Q34642023-05705C8D-11B0-4A5A-A4C9-079834DE3E9A

Q34642023-0FF38042-22DE-451F-8C70-C215898CA721

Q34642023-11A9BD22-57BD-4535-AEBE-A9A84869570B

Q34642023-1BC67FDD-51AD-441F-A4C5-66D699B97B62

Q34642023-2293DB7D-0B0F-4F9A-9D65-2293EE279012

Q34642023-2AA0BB38-0433-4B16-A5AD-7EAE50FFEC6F

Q34642023-2AB8E316-4D19-4DC9-B8B4-DE12F6509140

Q34642023-3118C5D5-ABFD-496A-9459-03839D3B7B58

Q34642023-32AE1734-ABDF-4108-A9A4-E94FA036F999

Q34642023-379E9C30-D496-4F10-9D2C-EA5225F12200

P304

Q34642023-B15F7238-9F19-4655-8683-C3C88CA54EFC

P31

Q34642023-80156200-8183-4B36-91D4-9977D5B4FEF5

P356

Q34642023-6DA0DE11-FFEC-42A4-956A-10D0094968F8

P433

Q34642023-2CD7BF46-113A-4A1B-B51A-8B9EAFF06CF8

P478

Q34642023-AAA23965-44D9-48FA-A914-1C17DC4CAE97

P577

Q34642023-3EEE1DE0-FB0E-4358-9ABD-9D316DB7D44D

P5875

Q34642023-E61E8B45-880F-406C-9FF8-759713FC286F

P698

Q34642023-4BF68466-873F-4E39-95F4-BCFCE37952F5

P921

Q34642023-3c773c61-360d-41a4-b224-a825c3c17d1b

P932

Q34642023-1639DD2E-A38C-4133-A484-343D8DB3C858

P356

J.ISSN.2078-6891.2012.021

P1433

Journal of gastrointestinal oncology

P1476

Gastric cancer: Classification, histology and application of molecular pathology.

@en

P2093

Aurelia Meloni-Ehrig

http://www.w3.org/2001/XMLSchema#string

Bing Hu

http://www.w3.org/2001/XMLSchema#string

Nancy Lammert

http://www.w3.org/2001/XMLSchema#string

Nassim El Hajj

http://www.w3.org/2001/XMLSchema#string

Robert Barnes

http://www.w3.org/2001/XMLSchema#string

Scott Sittler

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Genetic regulation of dihydropyrimidinase and its possible implication in altered uracil catabolism

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

HER2 testing in gastric cancer: a practical approach

Dihydropyrimidine dehydrogenase deficiency: impact of pharmacogenetics on 5-fluorouracil therapy

Time trend analysis of gastric cancer incidence in Japan by histological types, 1975-1989

Strong association of a common dihydropyrimidine dehydrogenase gene polymorphism with fluoropyrimidine-related toxicity in cancer patients

THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

P304

251-261

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3978/J.ISSN.2078-6891.2012.021

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230784855

http://www.w3.org/2001/XMLSchema#string

P698

22943016

http://www.w3.org/2001/XMLSchema#string

P921

P932

3418539

http://www.w3.org/2001/XMLSchema#string